Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

WIL Research Partners with Three S Japan

Published: Friday, May 24, 2013
Last Updated: Friday, May 24, 2013
Bookmark and Share
Partnership to expand full portfolio of global safety assessment services to the Japanese market.

WIL Research is partnering with Three S Japan, a company that provides support services in these industries, to represent its full portfolio of global safety assessment services in Japan.

WIL Research offers a blend of technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry and formulation services.

They chose the Japan-based company to represent these services on the basis of its extensive network of clients, leadership experience with both pharmaceutical and chemical industry safety assessment, and its commitment to providing tailored, local client service.

“Three S Japan has a strong reputation serving the country’s pharmaceutical industry with high quality regulatory services underpinned by exceptional client focus,” said David Spaight, Chairman and CEO of WIL Research.

Spaight continued, “Through this partnership, clients will benefit from direct access to staff that can harness the full portfolio of WIL Research’s global services.”

CEO and President of Three S Japan, Koichi Hagita said, “WIL Research’s excellent reputation and our long-term client relationships and regulatory experience in the Japanese market will boost both our companies’ potential for growth.”

Three S Japan has operational centers in Tokyo and Osaka for pharmaceutical regulatory registration services.

The company provides toxicological support from pre-clinical to clinical development, and is experienced in the preparation, translation, and quality control checks of submission documents for New Drug Applications and Investigational New Drug applications.

Three S Japan also offers personalized consulting tailored to clients’ needs.

WIL Research was recently one of the winners of the CRO Leadership Award for Quality, awarded annually to leaders in quality, productivity, regulatory, accessibility, and reliability.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

WIL Research Acquires Ricerca Facility in Lyon, France
The addition of the 18,000-square meter facility fortifies WIL Research’s service offerings in Europe.
Friday, June 21, 2013
WIL Research Acquires Ricerca Facility in Lyon, France
The addition of the 18,000-square meter facility fortifies WIL Research’s service offerings in Europe.
Friday, June 21, 2013
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Salford Lung Study - The First Real World Clinical Trial
In this podcast, we learn about the Salford Lung Study and its potential to revolutionize the way we assess new drugs and treatments around the world.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Preventing "Friendly Fire" in the Pancreas
Researchers inhibit process that leads to the body attacking its own insulin-producing cells.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanomedicine for Breast Cancer Treatment
Using nanoparticles measuring only billionths of a meter in size, doctors are able to deliver drug molecules directly to the affected tissue.
MRSA Uses Decoys to Evade a Last-Resort Antibiotic
Researchers at Imperial College London have discovered that MRSA releases decoy molecules that allow them to escape being killed by the antibiotic.
MRIs for Fetal Health
Algorithm could help analyze fetal scans to determine whether interventions are warranted.
RNA-Binding Proteins Role in ALS Revealed
Researchers describe how damage to RNA-binding protein contributes to ALS, isolating a possible therapeutic target.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos